Jin Yan Jin (Jin Jin, Jin Y Jin)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 38

Top Topics

Hodgkin Lymphoma

Machine Learning

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Gengbo Liu, Logan Brooks, John T Canty, Dan Lu, Jin Yan Jin, James Lu
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Joy C Hsu, Michael Wu, Chloe Kim, Bianca Vora, Yi Ting Kayla Lien, Ashutosh Jindal, Kenta Yoshida, Sonoko Kawakatsu, Jeremy Gore, Jin Yan Jin, Christina Lu, Bingyuan Chen, Benjamin Wu
Applications of Advanced Natural Language Processing for Clinical Pharmacology. Clinical pharmacology and therapeutics 115 (4) (2024)
Joy C Hsu, Michael Wu, Chloe Kim, Bianca Vora, Yi Ting Kayla Lien, Ashutosh Jindal, Kenta Yoshida, Sonoko Kawakatsu, Jeremy Gore, Jin Yan Jin, Christina Lu, Bingyuan Chen, Benjamin Wu
Applications of Advanced Natural Language Processing for Clinical Pharmacology. Clinical pharmacology and therapeutics 115 (4) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Gengbo Liu, Logan Brooks, John T Canty, Dan Lu, Jin Yan Jin, James Lu
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gengbo Liu, Logan Brooks, John T Canty, Dan Lu, Jin Yan Jin, James Lu
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gengbo Liu, Logan Brooks, John T Canty, Dan Lu, Jin Yan Jin, James Lu
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data. CPT: pharmacometrics & systems pharmacology (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology (2024)
Gengbo Liu, Logan Brooks, John T Canty, Dan Lu, Jin Yan Jin, James Lu
Deep-NCA: A deep learning methodology for performing noncompartmental analysis of pharmacokinetic data. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Mathilde Marchand, Antonio Gonçalves, Francois Mercier, Pascal Chanu, Jin Yan Jin, Jeremie Guedj, René Bruno
Tumor growth and overall survival modeling to support decision making in phase Ib/II trials: A comparison of the joint and two-stage approaches. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Joy C Hsu, Michael Wu, Chloe Kim, Bianca Vora, Yi Ting Kayla Lien, Ashutosh Jindal, Kenta Yoshida, Sonoko Kawakatsu, Jeremy Gore, Jin Yan Jin, Christina Lu, Bingyuan Chen, Benjamin Wu
Applications of Advanced Natural Language Processing for Clinical Pharmacology. Clinical pharmacology and therapeutics 115 (4) (2024)
Brendan Bender, Chi-Chung Li, Mathilde Marchand, David C Turner, Feifei Li, Shweta Vadhavkar, Bei Wang, Rong Deng, James Lu, Jin Yan Jin, Chunze Li, Shen Yin, Michael Wei, Pascal Chanu
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma. Clinical and translational science 17 (6) (2024)
Tong Lu, Victor Poon, Logan Brooks, Erick Velasquez, Eric Anderson, Kyle Baron, Jin Yan Jin, Matts Kagedal
gPKPDviz: A flexible R Shiny tool for pharmacokinetic/pharmacodynamic simulations using mrgsolve. CPT: pharmacometrics & systems pharmacology (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics 113 (4) (2023)
Joy C Hsu, Michael Wu, Chloe Kim, Bianca Vora, Yi Ting Kayla Lien, Ashutosh Jindal, Kenta Yoshida, Sonoko Kawakatsu, Jeremy Gore, Jin Yan Jin, Christina Lu, Bingyuan Chen, Benjamin Wu
Applications of Advanced Natural Language Processing for Clinical Pharmacology. Clinical pharmacology and therapeutics (2023)
Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Yan Jin, Angelica L Quartino, Joy C Hsu, null null
Modeling Alzheimer's Disease Progression Utilizing Clinical Trial and ADNI Data to Predict Longitudinal Trajectory of CDR-SB. CPT: pharmacometrics & systems pharmacology (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics 113 (4) (2023)
Rashed Harun, Rucha Sane, Kenta Yoshida, Dhruvitkumar S Sutaria, Jin Yan Jin, James Lu
Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning-Based Investigation. JCO clinical cancer informatics 7 (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate Pharmacometric Model to Define the Impact of Second-Line Immunotherapies on the Survival Outcome of the IMpower131 Study. Clinical pharmacology and therapeutics (2023)
Mohamed H Shahin, Aline Barth, Jagdeep T Podichetty, Qi Liu, Navin Goyal, Jin Yan Jin, Daniele Ouellet
Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology. Clinical pharmacology and therapeutics (2023)
Stephan Schmidt, Valvanera Vozmediano, Rodrigo Cristofoletti, Sarah Kim, Zhoumeng Lin, Natalia Valadares De Moraes, Francine Azeredo, Brian Cicali, Hans Leuenberger, Joshua D Brown, Jin Yan Jin, Cynthia J Musante, Stacey Tannenbaum, Yaning Wang
Requirements, expectations, challenges and opportunities associated with training the next generation of pharmacometricians. CPT: pharmacometrics & systems pharmacology 12 (7) (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Rashed Harun, Rucha Sane, Kenta Yoshida, Dhruvitkumar S Sutaria, Jin Yan Jin, James Lu
Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning-Based Investigation. JCO clinical cancer informatics 7 (2023)
Rashed Harun, Rucha Sane, Kenta Yoshida, Dhruvitkumar S Sutaria, Jin Yan Jin, James Lu
Risk Factors of Hyperglycemia After Treatment With the AKT Inhibitor Ipatasertib in the Prostate Cancer Setting: A Machine Learning-Based Investigation. JCO clinical cancer informatics 7 (2023)
Antonio Gonçalves, Mathilde Marchand, Phyllis Chan, Jin Yan Jin, Jeremie Guedj, René Bruno
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer. CPT: pharmacometrics & systems pharmacology (2023)
Sreenath M Krishnan, Lena E Friberg, Francois Mercier, Rong Zhang, Benjamin Wu, Jin Yan Jin, Tien Hoang, Marcus Ballinger, René Bruno, Mats O Karlson
Multistate pharmacometric model to define the impact of second-line immuno-therapies on the survival outcome of IMpower131 study. Clinical pharmacology and therapeutics (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor dynamic model-based decision support for Phase Ib/II combination studies: A retrospective assessment based on resampling of the Phase III study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joy C Hsu, Michael Wu, Chloe Kim, Bianca Vora, Yi Ting Kayla Lien, Ashutosh Jindal, Kenta Yoshida, Sonoko Kawakatsu, Jeremy Gore, Jin Yan Jin, Christina Lu, Bingyuan Chen, Benjamin Wu
Applications of Advanced Natural Language Processing for Clinical Pharmacology. Clinical pharmacology and therapeutics (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Yan Jin, Angelica L Quartino, Joy C Hsu, null null
Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB. CPT: pharmacometrics & systems pharmacology (2023)
René Bruno, Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou, Francois Mercier, Pascal Chanu, Benjamin Wu, Anthony Lee, Chunze Li, Jin Yan Jin, Michael L Maitland, Martin Reck, Mark A Socinski
Tumor dynamic model-based decision support for Phase Ib/II combination studies: A retrospective assessment based on resampling of the Phase III study IMpower150. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gengbo Liu, James Lu, Hong Seo Lim, Jin Yan Jin, Dan Lu
Applying interpretable machine learning workflow to evaluate exposure-response relationships for large-molecule oncology drugs. CPT: pharmacometrics & systems pharmacology (2022)
Vidya Ramakrishnan, Christina Friedrich, Colleen Witt, Robert Sheehan, Meghan Pryor, Jasvinder K Atwal, Kristin Wildsmith, Katherine Kudrycki, Seung-Hye Lee, Norman Mazer, Carsten Hofmann, Reina N Fuji, Jin Yan Jin, Saroja Ramanujan, Michael Dolton, Angelica Quartino
Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates. CPT: pharmacometrics & systems pharmacology (2022)